14.03.2024 – 07:31STADA Arzneimittel AGPress release: STADA continues with double-digit sales and profit growth in 2023Ein Dokumentmehr
13.03.2024 – 16:21FDX Fluid Dynamix GmbH4FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiXmehr
28.02.2024 – 15:00RHEACELL GmbH und Co. KGResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘mehr
28.02.2024 – 11:07Helmholtz MunichRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Targetmehr
23.02.2024 – 10:28Leipzig Tourismus und Marketing GmbH5Pioneering Heart Surgery and Medical Congresses in LeipzigEin Dokumentmehr
22.02.2024 – 13:23Helmholtz MunichTherapeutic Vaccine for Chronic Hepatitis B Enters Clinical TrialMore information on the therapeutic vaccine TherVacBmehr
19.02.2024 – 17:05Helmholtz MunichWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and ComplicationsLearn more about research at Helmholtz Munichmehr
01.02.2024 – 10:02Sysmex Europe SEStrengthening the Direct Sales and Service System for Business Expansion in ItalyVisit our website!Ein Dokumentmehr
26.01.2024 – 13:50Biomay AGBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapymehr
06.12.2023 – 16:00LTS Lohmann Therapie-Systeme AGLTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patchesmehr
16.11.2023 – 10:27Fruit Vegetables EuropeTen benefits of a daily intake of citrus fruits during winter seasonmehr
31.10.2023 – 10:00ARTTIC Innovation GmbH2PIONEER+ becomes Big Data Platform for Prostate Cancer of the EAU's UroEvidenceHubPIONEER Videomehr
12.10.2023 – 14:01ARTTIC Innovation GmbH3EU Provides 1 Mio. to Researchers to Advance Personalised OncologycanSERV CallEin Dokumentmehr
12.10.2023 – 14:00ARTTIC Innovation GmbHcanSERV Releases Open Call for Transnational Service ProvisioncanSERV CallEin Dokumentmehr
02.10.2023 – 17:06Helmholtz MunichDeepMB: A Deep Learning Framework For High-Quality Optoacoustic Imaging in Real-Timemehr
30.08.2023 – 12:28STADA Arzneimittel AG2Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey revealsEin Dokumentmehr
15.08.2023 – 07:01STADA Arzneimittel AG2Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and SpecialtyEin Dokumentmehr
08.08.2023 – 08:00ARTTIC Innovation GmbH4PIONEER Big Data in Prostate Cancer Platform Opens up to Asian Data SetsMore about PIONEERmehr
05.07.2023 – 17:15Helmholtz MunichPotentiating Cancer Vulnerability to Ferroptosis: Off-Targeting Effects of DHODH Inhibitorsmehr
30.06.2023 – 10:09ARTTIC Innovation GmbH2CARAMBA: New Hope for Multiple Myeloma PatientsCARAMBA project websitemehr
28.06.2023 – 17:13Helmholtz MunichNew Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Inductionmehr
27.06.2023 – 11:23RHEACELL GmbH und Co. KGRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affectedmehr
15.06.2023 – 09:36Berlin CuresBerlin Cures Welcomes Oliver von Stein as New CEO to Lead Next Phase of Innovation and Growth / Phase II study for BC 007 in the indication Long COVID to start in Junemehr
24.04.2023 – 10:01Sysmex Europe SE3Sysmex Europe distributes MammaTyper®, an advanced breast cancer diagnostic assay, through the European distribution agreement with Cerca BiotechFind out more on MammaTyper here!mehr